Anne Gonzales-Luna, PharmD

Articles by Anne Gonzales-Luna, PharmD

Image credit: Saiful52 - stock.adobe.com

Clinical Overview: Fecal Microbiota Transplantation vs Live Biotherapeutic Products for Management of Recurrent C Difficile Infection

ByAnne Gonzales-Luna, PharmD,Glenn S Tillotson PhD, FIDSA

September 15th 2023

Although antibiotics are the standard-of-care treatment for Clostridioides difficile infection, they can cause further microbiota changes that predispose patients to recurrence.

Anne Gonzales-Luna, PharmD

Articles by Anne Gonzales-Luna, PharmD

Clinical Overview: Fecal Microbiota Transplantation vs Live Biotherapeutic Products for Management of Recurrent C Difficile Infection

Latest Updated Articles

Trending on Pharmacy Times

Evolving Mortality Trends in Heart Failure and Vascular Disease: The Critical Role of Pharmacists in Addressing Cardiovascular Risk

Targeting Mitochondrial Metabolism in Heart Failure: From Genetic Drivers to Fuel Modulation Therapies

Frequent Continuous Glucose Monitoring Linked to Greater HbA1C Reductions in Adults With T2D

SGLT2 Inhibitors Linked to Lower Atrial Fibrillation Risk, Recurrence

Sotatercept Demonstrates Significant Reduction in Morbidity and Mortality Across Broader PAH Risk Groups